Pseudohomozygous APC Resistance Report on Two Patients and a Novel Mutation in the Factor V Gene

Autor: F. H. Herrmann, B. Maak, P. Heuchel, L. Kochhan
Rok vydání: 2008
Předmět:
Zdroj: 37th Hemophilia Symposium ISBN: 9783540735342
DOI: 10.1007/978-3-540-73535-9_40
Popis: Resistance to activated protein C (APC resistance) was identified as the cause of familial thrombophilia by Dahlback et al. in 1993 [4]. Only one year later the underlying genetic defect of the APC resistance has been demonstrated by Bertina and colleagues [1]. APC resistance is the result of the point mutation G 1691 A within exon 10 of the factor V gene. This mutation was named as factor V mutation “Leiden” and results in an exchange of the amino acid arginine (R) to glutamine (Q) at position 506 of the factor V protein. The altered factor V molecule is resistant to cleavage by activated protein C. As a consequence, factor V acts as a procoagulant and a thrombotic tendency results. Homozygosity for the 1691 A allele carries a markedly increased risk (80–100 fold) for venous thromboembolism and in the heterozygous state the risk is 7–10 fold greater than in normal subjects.
Databáze: OpenAIRE